Sensient Technologies Corp Dossier - Source-backed chat

Sensient Technologies Corp

SXTNYSE

SectorMaterials

IndustrySpecialty Chemicals

Beta (adjusted)0.86

Intrinsic Value $98.95median of 6 methods · middle span $75-$121based on filings through 30 Jun 2026

Market Price $128.42Price as of 1 Oct 2026

OvervaluedIntrinsic value is 23% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $5.5B

Enterprise Value $6.2B

Shares Outstanding 42.8M diluted

Moat Rating Narrow

Next Earnings Date30 Oct 2026

Last ex-dividend3 Aug 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Sensient Technologies is uniquely positioned to capitalize on the accelerating global transition from synthetic to natural colors, driven by both consumer preferences and tightening regulatory standards. Following the successful completion of its $50 million Portfolio Optimization Plan, which is expected to deliver $8 million in annual cost savings starting in 2026, the company has demonstrated strong operating leverage. This is evidenced by its stellar Q1 2026 results, where local currency revenue grew 7.2% and adjusted EBITDA rose 10.4%. While heavy capital expenditures to support natural color capacity and rising debt levels warrant close monitoring, the company's upgraded full-year 2026 guidance and robust pipeline of complex, high-margin customer conversions support a highly constructive outlook.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets5 analysts · as of 18 Aug 2026

Low · most bearish analyst$133.00

Mean target$142.80

High · most bullish analyst$155.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$133.00

Customer reformulation timelines slip, delaying the revenue ramp from natural color conversions. Meanwhile, elevated capital expenditures and working capital requirements lead to higher debt levels and interest expenses, compressing net margins and limiting free cash flow generation.

Base CaseCentral scenario

$142.80

Matches the consensus mean

Sensient successfully executes its capacity expansion plans and steadily converts its pipeline of natural color customers. The company achieves high-single-digit local currency revenue and adjusted EBITDA growth in line with its upgraded 2026 guidance, supported by $8 million in annual cost savings from the completed portfolio optimization plan. Margins remain stable in the first half of the year and expand in the fourth quarter.

Bull CaseUpside scenario

$155.00

Accelerated regulatory bans on synthetic colorants (such as titanium dioxide alternatives) drive a faster-than-expected conversion to natural colors. Sensient's proprietary natural color formulations and vertically integrated supply chain allow it to capture market share rapidly, leading to double-digit local currency revenue growth and significant margin expansion as operating leverage kicks in.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Strong regulatory and consumer tailwinds driving the transition from synthetic to natural colors.
Completion of the $50 million Portfolio Optimization Plan, yielding $8 million in annual cost savings starting in 2026.
Vertical integration in key natural color raw materials, providing a defensive moat and ensuring quality and traceability.
Upgraded full-year 2026 GAAP EPS guidance to $3.70 - $3.90, reflecting strong operational momentum.

Key Investment Risks

Execution risk associated with customer reformulation and conversion timelines.
Elevated capital expenditures ($150 million - $170 million projected for 2026) putting temporary pressure on free cash flow.
Rising interest rates or debt levels as the company funds capacity expansion and working capital.

Thesis Invalidation Triggers

A significant delay or rollback of regulatory deadlines for synthetic color bans in key jurisdictions.
Net debt to credit-adjusted EBITDA rising consistently above 3.0x.
A material drop in Color Group volume growth, indicating a loss of market share to larger competitors.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.